Innovaccer
Innovaccer is a healthcare technology company. Its Data Activation Platform unifies patient records to enable collaborative care delivery.
Secondary Market Price
Secondary Market Price
How Innovaccer Measures Up
To help you manage your Innovaccer equity, Prospect has run the company through our machine learning model.
Prospect Rating
--
This rating reflects our belief in this company's potential to grow to that many times its current value in 4 years. For an employee with stock, this rating suggests a potential return on equity, but it also comes with some risk.
Exit Risk
--
Our rating is a reflection of the likelihood of this company achieving a liquidity event for its employees based on the quality of investors, funding stage, founders, and more.
Funding Stage
Series F
A company’s funding stage reflects how established it is, how quickly it is scaling, and the average impact an employee may have when joining.
Secondary Market Price Chart
Create a free account to unlock real-time secondary market prices and future projections of Innovaccer's value.
Sign up to Unlock the Latest DataData will be available soon.
Sign up to receive notifications when it is available.
Prospect Projected Future Innovaccer Prices
Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for Innovaccer's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.
Powerful tools to earn more from your equity
Company Description
Innovaccer is a healthcare technology company that provides a data platform for providers, payers, and life science organizations. Its main offering, the Healthcare Intelligence Cloud, also referred to as the Data Activation Platform, ingests data from disparate sources to create a unified patient record. This allows organizations to analyze information and coordinate care. Notable customers using this platform include CommonSpirit Health, Atlantic Health, and Banner Health. The company was founded in 2014 by Abhinav Shashank, Kanav Hasija, and Sandeep Gupta. Headquartered in San Francisco, California, Innovaccer also has major offices in Noida and Bengaluru, India. The company has raised over $423 million in total funding.
Looking forward, Innovaccer plans to expand its population health strategies to cover all patient populations, regardless of their payment model. The company continues to focus on advancing the use of unified data and AI-powered intelligence. Recent announcements reflect this direction, with the company planning to host its Xccelerate 2026 conference with a focus on healthcare AI and value-based care. Innovaccer is also participating in events like the Health AI Executive Summit and developing specialized solutions and brands, including Gravity by Innovaccer and Flow by Innovaccer, to further its platform's capabilities.
- B Capital Group
- Banner Health
- Danaher Ventures
- Generation Investment Management
- Kaiser Permanente
- M12
- Mubadala Capital
- Steadview Capital
- Dragoneer Investment Group
- Tiger Global Management
- OMERS Growth Equity
- Whale Rock Capital Management
- Avidity Partners
- Schonfeld Strategic Advisors
- WestBridge Capital
- Lightspeed India Partners
- Pravega Ventures
- Sequoia Capital India
- 500 Startups
- Co-Founder, Abhinav Shashank
- Co-Founder, Kanav Hasija
- Co-Founder, Sandeep Gupta
Peer Group Comparison
Vs Peer Group of >$4B Startups
Frequently Asked Questions
Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.
Is Innovaccer worth joining?
Deciding if a company is the right fit depends on your personal career goals and financial objectives. To better understand the potential value of your equity compensation, you can use platforms like Prospect to model future scenarios and project your potential earnings.
What should I do with my Innovaccer stock?
Managing your private company stock requires a personalized strategy based on your financial situation and goals. Tools like Prospect can help you create a custom plan for exercising options, minimizing taxes, and deciding when to sell your shares.
Can you sell Innovaccer stock?
Yes, it is often possible to sell shares in a private company like Innovaccer through secondary markets or company-approved tender offers. Platforms such as Prospect offer tools to help you determine the optimal amount and specific shares to sell for tax efficiency.
How can I find the value of my Innovaccer stock?
Since Innovaccer is a private company, its stock value isn't publicly listed, but you can use specialized tools to estimate it. Prospect uses proprietary predictive models to help you project the future value of your equity and understand its potential worth.
What is Innovaccer's equity worth?
The exact worth of private company equity fluctuates and is determined by factors like the latest valuation and secondary market demand. You can use a platform like Prospect to get a clearer picture by modeling your equity's potential future value based on various growth scenarios.
What is Innovaccer's stock ticker symbol?
As a private company, Innovaccer is not traded on a public stock exchange and therefore does not have a stock ticker symbol. Ticker symbols are only assigned to companies once they complete an Initial Public Offering (IPO).
Can I buy or sell Innovaccer stock?
Selling private stock is often possible during specific events like tender offers, and platforms like Prospect can help you navigate this process. Buying stock in a private company is typically restricted to accredited investors or employees participating in specific programs.
What is the criteria to buy or invest in Innovaccer stock?
Investing in a private company like Innovaccer is typically limited to institutional investors, venture capital firms, or accredited investors who meet specific wealth or income thresholds. These opportunities are not generally available to the public.
